BruceESandsMDFACEP

PubMed

• 10 citations
  Microscopic heterogeneity in ulcerative colitis: implications for microscopic measurement of disease activity.
  Noam Harpaz, Samuel Ballentine, Jean-Frederic Colombel, Bruce E. Sands, Huabin Mabel Ko> ;Gut. 2020 Feb 1
• 114 citations
  IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
  Stephen B. Hanauer, William J. Sandborn, Brian G. Feagan, Christopher Gasink, Douglas Jacobstein, Bin Zou, Jewel Johanns, Omoniyi J. Adedokun, Bruce E. Sands, Paul Rut...> ;Journal of Crohn's & Colitis. 2020 Jan 1
• 38 citations
  Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases
  Parambir S. Dulai, Laurent Peyrin-Biroulet, Silvio Danese, Bruce E. Sands, Axel Dignass, Dan Turner, Gerassimos J. Mantzaris, Juergen Schölmerich, Jean-Yves Mary, Walt...> ;Gastroenterology. 2019 Oct 1
• 6 citations
  The Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis.
  Bruce E. Sands, Adam S. Cheifetz, Chudy I. Nduaka, Daniel Quirk, Wenjin Wang, E Maller, Gary S. Friedman, Chinyu Su, Peter D.R. Higgins> ;Journal of Crohn's & Colitis. 2019 Sep 19
• 16 citations
  A Longitudinal Study of Sexual Function in Women With Newly Diagnosed Inflammatory Bowel Disease.
  Eugenia Shmidt, Mayte Suárez-Fariñas, Meaghan Mallette, Heather Moniz, Renee Bright, Samir A. Shah, Marjorie Merrick, Jason Shapiro, Fang Xu, Bruce E. Sands, Sumona Saha> ;Inflammatory Bowel Diseases. 2019 Jun 18
• 55 citations
  Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort
  Bryce Perler, Ryan C. Ungaro, Grayson L. Baird, Meaghan Mallette, Renee Bright, Samir A. Shah, Jason Shapiro, Bruce E. Sands> ;BMC Gastroenterology. 2019 Apr 2
• Response to Chamberlin and Borody.
  Gary R. Lichtenstein, Edward V. Loftus, Kim L. Isaacs, Miguel Regueiro, Bruce E. Sands> ;The American Journal of Gastroenterology. 2019 Jan 1
• 82 citations
  Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study.
  Bruce E. Sands, William J. Sandborn, Brian G. Feagan, Gary R. Lichtenstein, Hongyan Zhang, Richard Strauss, Philippe Szapary, Jewel Johanns, Julián Panés, Severine Ver...> ;Journal of Crohn's & Colitis. 2018 Nov 9
• 48 citations
  Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
  Eugenia Shmidt, Gursimran Kochhar, Justin Hartke, Prianka Chilukuri, Joseph Meserve, Khadija Chaudrey, Jenna L. Koliani-Pace, Robert Hirten, David Faleck, Morris Baroc...> ;Inflammatory Bowel Diseases. 2018 Oct 12
• 48 citations
  Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis
  Hans H Herfarth, Edward L. Barnes, John F. Valentine, John S. Hanson, Peter D.R. Higgins, Kim L. Isaacs, Susan A. Jackson, Mark T. Osterman, Kristen Anton, Anastasia I...> ;Gastroenterology. 2018 Oct 1
• 15 citations
  The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn's Disease.
  Bruce E. Sands, C. Han, Christopher Gasink, Douglas Jacobstein, Philippe Szapary, Long-Long Gao, Yinghua Lang, Stephan R. Targan, William J. Sandborn, Brian G. Feagan> ;Journal of Crohn's & Colitis. 2018 Jul 30
• 701 citations
  ACG Clinical Guideline: Management of Crohn’s Disease in Adults
  Gary R. Lichtenstein, Edward V. Loftus, Kim L. Isaacs, Miguel Regueiro, Lauren B. Gerson, Bruce E. Sands> ;The American Journal of Gastroenterology. 2018 Apr 1
• 30 citations
  Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease.
  Silvio Danese, Stefanos Bonovas, Anthony Lopez, Gionata Fiorino, William J. Sandborn, David T. Rubin, Michael A. Kamm, Jean-Frederic Colombel, Bruce E. Sands, Severine...> ;Gastroenterology. 2018 Jul 1
• 87 citations
  Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease—an International, Cross-disciplinary Consensus
  Andrew H. Kim, Charlotte Roberts, Brian G. Feagan, Rupa Banerjee, Willem A. Bemelman, Keith Bodger, Marc Derieppe, Axel Dignass, Richard Driscoll, Ray Fitzpatrick, Jan...> ;Journal of Crohn's & Colitis. 2018 Mar 28
• 12 citations
  Luminally polarized mural and vascular remodeling in ileal strictures of Crohn's disease.
  Huaibin M. Ko, Joana Torres, Hinaben J. Panchal, Zhenjian Cai, Mathilde Wagner, Bruce E. Sands, Jean-Frederic Colombel, Judy H. Cho, Bachir Taouli, Noam Harpaz> ;Human Pathology. 2018 Mar 16
• 11 citations
  Opportunistic screening for bone disease using abdominal CT scans obtained for other reasons in newly diagnosed IBD patients
  Dionne Rebello, D. Anjelly, David J. Grand, Jason T. Machan, Michael D. Beland, M. S. Furman, Jason Shapiro, Neal S. Leleiko, Bruce E. Sands, Meaghan Mallette, Renee B...> ;Osteoporosis International. 2018 Mar 8
• 5 citations
  When Do You Start and When Do You Stop Screening for Colon Cancer in Inflammatory Bowel Disease
  Millie D. Long, Bruce E. Sands> ;Clinical Gastroenterology and Hepatology. 2018 May 1
• 2 citations
  What Is the Role of the Inflammatory Bowel Disease Panel in Diagnosis and Treatment
  Millie D. Long, Bruce E. Sands> ;Clinical Gastroenterology and Hepatology. 2018 May 1
• 30 citations
  Accelerated Infliximab Dosing Increases 30-Day Colectomy in Hospitalized Ulcerative Colitis Patients: A Propensity Score Analysis.
  Shailja C. Shah, Steven Naymagon, Hinaben J. Panchal, Bruce E. Sands, Benjamin L. Cohen, Marla Dubinsky> ;Inflammatory Bowel Diseases. 2018 Feb 15
• 86 citations
  Development of an index to define overall disease severity in IBD
  Corey A. Siegel, Cynthia B. Whitman, Brennan Spiegel, Brian G. Feagan, Bruce E. Sands, Edward V. Loftus, Remo Panaccione, Geert R. D'Haens, Charles N. Bernstein, Richa...> ;Gut. 2018 Feb 1
• 53 citations
  Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn’s Disease
  Brian G. Feagan, Bruce E. Sands, Guillermo Rossiter, Xiaobin Li, Keith Usiskin, Xiaojiang Zhan, Jean-Frederic Colombel> ;Gastroenterology. 2018 Jan 1
• 20 citations
  Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies.
  Julian Panés, Séverine Vermeire, James O Lindsay, Bruce E Sands, Chinyu Su, Gary Friedman, Haiying Zhang, Aaron Yarlas, Martha Bayliss, Stephen Maher, Joseph C Cappell...> ;Journal of Crohn's & Colitis. 2018 Jan 24
• 531 citations
  The safety of vedolizumab for ulcerative colitis and Crohn's disease
  Jean-Frederic Colombel, Bruce E. Sands, Paul Rutgeerts, William J. Sandborn, Silvio Danese, Geert R. D'Haens, Remo Panaccione, Edward V. Loftus, Serap Sankoh, I. Fox, ...> ;Gut. 2017 May 1
• 2 citations
  The Whys and Hows of Fourth-Year Inflammatory Bowel Disease Fellowships.
  Robert Hirten, Bruce E. Sands, Benjamin L. Cohen> ;Digestive Diseases and Sciences. 2017 May 1
• 45 citations
  Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease.
  Maria Rosario, Jonathan L French, Nathanael L Dirks, Serap Sankoh, Asit Parikh, Huyuan Yang, Silvio Danese, Jean-Frédéric Colombel, Michael Smyth, William J Sandborn, ...> ;Journal of Crohn's & Colitis. 2017 Aug 1
• Join now to see all